keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BQ-123 is a selective endothelin A receptor (ETA) antagonist with IC50 of 7.3 nM. Phase 2.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 80.00 | |
5 mg | In stock | $ 328.00 | |
10 mg | In stock | $ 562.00 | |
25 mg | In stock | $ 861.00 | |
50 mg | In stock | $ 1,180.00 | |
100 mg | In stock | $ 1,580.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 443.00 |
Description | BQ-123 is a selective endothelin A receptor (ETA) antagonist with IC50 of 7.3 nM. Phase 2. |
Targets&IC50 | ETA receptor:7.3 nM |
In vitro | In porcine aortic vascular smooth muscle cells, BQ-123 selectively inhibits ETA-mediated contraction. [1] In rat vascular smooth muscle cells, BQ-123 inhibits endothelin-1-induced phosphoinositide breakdown and DNA synthesis. [2] |
In vivo | In rats, BQ-123 (1 mg/kg, i.v.) ameliorates myocardial ischemic-reperfusion injury. [3] In rats with pentylenetetrazole (PTZ)-induced tonic-clonic seizures, BQ-123 (3 mg/kg, i.v.) potently impedes the formation and spread of seizure. [4] In pregnant C57BL/6 mice, BQ-123 (6.7 mg/kg, i.p.) prevents LPS-induced preterm birth in mice via the induction of uterine and placental IL-10. [5] |
Synonyms | BQ123 |
Molecular Weight | 610.7 |
Formula | C31H42N6O7 |
CAS No. | 136553-81-6 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: 12 mg/mL (19.6 mM)
DMSO: 93 mg/mL (152.3 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BQ-123 136553-81-6 GPCR/G Protein Endothelin Receptor inhibit blood artery pressure muscle smooth BQ 123 cells Inhibitor pulmonary BQ123 inhibitor